Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2011 | 2 |
2019 | 2 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Clinical and Dermoscopic Findings of Nevi after Photoepilation: A Review.
Life (Basel). 2023 Aug 29;13(9):1832. doi: 10.3390/life13091832.
Life (Basel). 2023.
PMID: 37763236
Free PMC article.
Review.
PD-L1 Gene Polymorphisms rs822336 G>C and rs822337 T>A: Promising Prognostic Markers in Triple Negative Breast Cancer Patients.
Makrantonakis AE, Zografos E, Gazouli M, Dimitrakakis K, Toutouzas KG, Zografos CG, Kalapanida D, Tsiakou A, Samelis G, Zagouri F.
Makrantonakis AE, et al. Among authors: tsiakou a.
Medicina (Kaunas). 2022 Oct 6;58(10):1399. doi: 10.3390/medicina58101399.
Medicina (Kaunas). 2022.
PMID: 36295559
Free PMC article.
Item in Clipboard
Evaluation of MET T1010I and MET rs40239 single-nucleotide polymorphisms in triple-negative breast cancer: a case-control study.
Kalapanida D, Zagouri F, Gazouli M, Tsiakou A, Zografos E, Dimitrakakis C, Marinopoulos S, Giannos A, Sergentanis TN, Kastritis E, Terpos E, Dimopoulos MA.
Kalapanida D, et al. Among authors: tsiakou a.
Onco Targets Ther. 2019 May 28;12:4195-4202. doi: 10.2147/OTT.S189329. eCollection 2019.
Onco Targets Ther. 2019.
PMID: 31213837
Free PMC article.
Item in Clipboard
Prognostic significance of miR-34 rs4938723 T > C polymorphism in triple negative breast cancer patients.
Tsiakou A, Zagouri F, Zografos E, Samelis G, Gazouli M, Kalapanida D, Giannos A, Marinopoulos S, Dimitrakakis K, Lazaris C A, Rigopoulos D, Zografos G.
Tsiakou A, et al.
Clin Biochem. 2019 Jun;68:9-14. doi: 10.1016/j.clinbiochem.2019.03.009. Epub 2019 Mar 29.
Clin Biochem. 2019.
PMID: 30935968
Item in Clipboard
Survival benefit with the combination of docetaxel, gemcitabine and erlotinib in advanced and/or metastatic pancreatic cancer patients.
Samelis GF, Ekmektzoglou K, Tsiakou A, Giannakaki S, Konstadoulakis M.
Samelis GF, et al. Among authors: tsiakou a.
Hepatogastroenterology. 2011 Sep-Oct;58(110-111):1776-81. doi: 10.5754/hge10455. Epub 2011 Jul 15.
Hepatogastroenterology. 2011.
PMID: 21940348
Item in Clipboard
The continuation of bevacizumab following disease progression in patients with metastatic colorectal cancer offers a survival benefit.
Samelis GF, Ekmektzoglou KA, Tsiakou A, Konstadoulakis M.
Samelis GF, et al. Among authors: tsiakou a.
Hepatogastroenterology. 2011 Nov-Dec;58(112):1968-71. doi: 10.5754/hge11179.
Hepatogastroenterology. 2011.
PMID: 22024069
Item in Clipboard
Cite
Cite